Medicenna Therapeutics Co... (MDNA)
0.16
0.00 (1.91%)
At close: Jan 16, 2025, 9:00 PM
Medicenna Therapeutics Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for MDNA stock have an median target of 2.5, with a low estimate of 2.5 and a high estimate of 2.5. The median target predicts an increase of 1462.50% from the current stock price of 0.16.
Latest Analyst Insight Report
According to 1 stock analyst, the rating for Medicenna Therapeutics Corp. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
Financial Forecast this Year
Revenue This Year
488.52K
from 0
Increased by -%
Revenue Next Year
488.52K
from 488.52K
Increased by 0.0%
EPS This Year
-0.26
from 0.02
Increased by -1.2K%
EPS Next Year
-0.29
from -0.26
Increased by -11.5%